Immunoglobulins, also known as antibodies, are glycoprotein molecules produced by plasma cells. They act as a critical part of the immune response by specifically recognizing and binding to particular antigens, such as bacteria or viruses, and aiding in their destruction. The global Immunoglobulin market is projected to rise at a considerable rate during the forecast period.
The increasing incidence of diseases related to neurology, immunology, hematology, and other deficiencies, the growing ageing population across the world, improving healthcare infrastructure are some key factors boosting the growth of the Immunoglobulin market. Additionally, increasing adoption, and awareness of effective immunoglobulins products, and rich product pipeline are anticipated to propel the global immunoglobulins market during the forecast period. Furthermore, rising investments by key players through collaborations, mergers, and acquisitions are projected to enlarge the growth of the global immunoglobulins market throughout the forecast period.
On the downside, the high cost of treatments and severe side effects related to infusions are expected to hamper the growth of the immunoglobulins market.
Covid-19 Impact on Immunoglobulin Market
In addition, the current Immunoglobulin Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Immunoglobulin Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Immunoglobulin Market Segment Overview
Based on the Applications, the Neurology segment dominates the global Immunoglobulins market due to its indication prevalence. Further, the Immunology segment is projected to expand at a significant rate owing to the higher prevalence of idiopathic thrombocytopenic purpura (ITP), primary immunodeficiency, and other indications. By Route of Administration, Intravenous held a maximum share in the market and is anticipated to maintain its position during the forecast period. This is due to its rapid onset of action. On the other hand, various benefits of subcutaneous over intravenous are now gradually adaptable in the market and hence, the subcutaneous segment is anticipated to expand at a substantial rate over the forecast period.
Immunoglobulin Market, By Applications
· Neurology
· Immunology
· Hematology
· Others
Immunoglobulin Market, By Route of Administration
· Intravenous
· Subcutaneous
· Intramuscular
Immunoglobulin Market, By End-User
· Hospital
· Clinic
· Homecare
Immunoglobulin Regional Overview
Region-wise, North America commanded a major share of the global Immunoglobulins market and is predictable to maintain its supremacy over the forecast period. This can be mainly attributed to the factors such as huge acceptance of intravenous infusions, growing plasma yield, ample healthcare investments by the government, and the presence of major players in the region. Additionally, the increasing incidence of neurological, autoimmune disorders is rising the demand for effective treatment, which in turn is a key factor boosting the growth of the market in North America. Similarly, the market of the Asia Pacific is projected to grow at the fastest rate in the forthcoming period. Several important factors such as emerging health care infrastructure, growing investments in research and development, growing awareness about IVIG infusions in countries, such as China and India, and increasing acceptance of SCIG infusions in the region are contributing more to the development of the market in this region. In addition, the incidence of CIDP, ITP diseases is estimated to further propel the market in the Asia Pacific in the coming years.
Immunoglobulin Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Immunoglobulin Market Competitor overview
Some key developments and strategies adopted by manufacturers in Immunoglobulin are highlighted below.
· In August 2021, The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to Bharat Serums and Vaccine Limited to manufacture the additional strength of 150 mcg of Recombinant Anti Rho-D Immunoglobulin Injection.
· In August 2021, GC Pharma reported positive top-line results from the phase 3 clinical trial of its immunoglobulin product GC5107. The study results showed GC5107 met the US Food and Drug Administration’s efficacy and safety requirements.
Immunoglobulin Market, Key Players
· Shire
· CSL Behring
· Kedrion Biopharma Inc
· Grifols, S.A.
· Octapharma
· China Biologic Products Holdings Inc
· Biotest AG
· Sanquin
· LFB SA.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Immunoglobulin Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Applications
- 5.2.1. Neurology
- 5.2.2. Immunology
- 5.2.3. Hematology
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By Route of Administration
- 5.3.1. Intravenous
- 5.3.2. Subcutaneous
- 5.3.3. Intramuscular
- 5.4. Market Analysis, Insights and Forecast – By End-User
- 5.4.1. Hospital
- 5.4.2. Clinic
- 5.4.3. Homecare
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Immunoglobulin Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Applications
- 6.2.1. Neurology
- 6.2.2. Immunology
- 6.2.3. Hematology
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By Route of Administration
- 6.3.1. Intravenous
- 6.3.2. Subcutaneous
- 6.3.3. Intramuscular
- 6.4. Market Analysis, Insights and Forecast – By End-User
- 6.4.1. Hospital
- 6.4.2. Clinic
- 6.4.3. Homecare
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Immunoglobulin Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Applications
- 7.2.1. Neurology
- 7.2.2. Immunology
- 7.2.3. Hematology
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By Route of Administration
- 7.3.1. Intravenous
- 7.3.2. Subcutaneous
- 7.3.3. Intramuscular
- 7.4. Market Analysis, Insights and Forecast – By End-User
- 7.4.1. Hospital
- 7.4.2. Clinic
- 7.4.3. Homecare
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Immunoglobulin Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Applications
- 8.2.1. Neurology
- 8.2.2. Immunology
- 8.2.3. Hematology
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By Route of Administration
- 8.3.1. Intravenous
- 8.3.2. Subcutaneous
- 8.3.3. Intramuscular
- 8.4. Market Analysis, Insights and Forecast – By End-User
- 8.4.1. Hospital
- 8.4.2. Clinic
- 8.4.3. Homecare
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Immunoglobulin Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Applications
- 9.2.1. Neurology
- 9.2.2. Immunology
- 9.2.3. Hematology
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By Route of Administration
- 9.3.1. Intravenous
- 9.3.2. Subcutaneous
- 9.3.3. Intramuscular
- 9.4. Market Analysis, Insights and Forecast – By End-User
- 9.4.1. Hospital
- 9.4.2. Clinic
- 9.4.3. Homecare
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Shire
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. CSL Behring
- 10.6. Kedrion Biopharma Inc
- 10.7. Grifols, S.A.
- 10.8. Octapharma
- 10.9. China Biologic Products Holdings Inc
- 10.10. Biotest AG
- 10.11. Sanquin
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
